Force limited vibration testing

A new method of conducting lab vibration tests of spacecraft equipment was developed to more closely simulate the vibration environment experienced when the spacecraft is launched on a rocket. The improved tests are tailored to identify equipment design and workmanship problems without inducing artificial failures that would not have occurred at launch. These new, less destructive types of vibration tests are essential to JPL's protoflight test approach in which lab testing is conducted using the flight equipment, often one of a kind, to save time and money. In conventional vibration tests, only the input vibratory motion is specified; the feedback, or reaction force, between the test item and the vibration machine is ignored. Most test failures occur when the test item goes into resonance, and the reaction force becomes very large. It has long been recognized that the large reaction force is a test artifact which does not occur with the lightweight, flexible mounting structures characteristic of spacecraft and space vehicles. In new vibration tests, both the motion and the force provided to the test item by the vibration machine are controlled, so that the vibration ride experienced by the test item is as in flight

Acoustic transmission through a fuselage sidewall

A definition is given of an idealized fuselage sidewall structure and a simplified analytical model for determining acoustical transmission from the exterior to the interior of a fuselage was constructed. The representation of the sidewall structure chosen for the analytical model excludes complicating effects such as cabin pressurization, acoustic transmission through windows or door seal leaks, aerodynamic excitation, and structural vibration excitation of the fuselage skin

Evaluation of the NASA Ames no. 1 7 by 10 foot wind tunnel as an acoustic test facility

Measurements were made in the no. 1 7'x10' wind tunnel at NASA Ames Research Center, with the objectives of defining the acoustic characteristics and recommending minimum cost treatments so that the tunnel can be converted into an acoustic research facility. The results indicate that the noise levels in the test section are due to (a) noise generation in the test section, associated with the presence of solid bodies such as the pitot tube, and (b) propagation of acoustic energy from the fan. A criterion for noise levels in the test section is recommended, based on low-noise microphone support systems. Noise control methods required to meet the criterion include removal of hardware items for the test section and diffuser, improved design of microphone supports, and installation of acoustic treatment in the settling chamber and diffuser

Acoustical properties of materials and muffler configurations for the 80 by 120 foot wind tunnel

Techniques for measuring the impedance of the muffler configurations and of porous plates with grazing flow were investigated and changes in the configuration parameters to enhance acoustic performance are explored. The feasibility of a pulse reflection technique for measuring the impedance of built-up structures in situ was demonstrated. A second technique involving the use of an open-end impedance tube with grazing flow was used to obtain detailed design data for the perforated plate configuration. Acoustic benefits associated with configuration changes such as curving the baffles, spacing and staggering baffle partitions, and techniques for alleviating baffle self-generated noise are described

Antiviral Activity of Favipiravir (T-705) Against Lethal Rift Valley Fever Virus Infection in Hamsters

Rift Valley Fever is a zoonotic, arthropod-borne disease that adversely affects ungulates and people. The etiologic agent, Rift Valley fever virus (RVFV; Bunyaviridae, Phlebovirus), is primarily transmitted through mosquito bites, yet can be transmitted by exposure to infectious aerosols. Presently, there are no licensed vaccines or therapeutics to prevent or treat severe RVFV infection in humans. We have previously reported on the activity of favipiravir (T-705) against the MP-12 vaccine strain of RVFV and other bunyaviruses in cell culture. Additionally, efficacy has been documented in mouse and hamster models of infection with the related Punta Toro virus. Here, we characterize a hamster RVFV challenge model and use it to evaluate the activity of favipiravir against the highly pathogenic ZH501 strain of the virus. Subcutaneous RVFV challenge resulted in substantial serum and tissue viral loads and caused severe disease and mortality within 2-3 days after infection. Oral favipiravir (200 mg/kg/day) prevented mortality in 60% or greater in hamsters challenged with RVFV when administered within 6 h post-exposure and reduced RVFV titers in serum and tissues relative to the time of treatment initiation. In contrast, although ribavirin (75 mg/kg/day) was effective at protecting animals from the peracute RVFV disease, most ultimately succumbed from a delayed-onset neurologic disease associated with high RVFV burden in the brain observed in moribund animals. When combined, T-705 and ribavirin treatment started 24 h post-infection significantly improved survival outcome and reduced serum and tissue virus titers compared to monotherapy. Our findings demonstrate significant post-RVFV exposure efficacy with favipiravir against both peracute disease and delayed-onset neuroinvasion, and suggest added benefit when combined with ribavirin

Using Strat Columns to Interpret Sequence Stragraphy of Glacial Driven Stream Deposits of the Acient San Joaquin River

The sedimentary deposits of the ancient San Joaquin River tell the story of river flow through three glacial periods. A strat column shows vertical changes in deposition throughout an outcrop. It can be used to extrapolate the energy level of the flow, and other features of the river at different depositional environments. By looking at trends through the column it is possible to determine how the river’s flow changed through time. Variances in the gravel size and whether it supports itself or is held together by the surrounding sand matrix give clues as to the rate of flow and how likely the sediment is to settle out of suspension. Finer grains settle out in lower energy flow. A strat column shows cycles of these trends that may potentially correlate with global climatic cycles

Shock transmission in coupled beams and rib stiffened structures

Shock transmission in a simple coupled beam structure and in a ring-stringer stiffened cylinder is investigated experimentally and analytically using wave transmission and statistical energy analysis concepts. The use of the response spectrum to characterize the excitation provided to a simple beam by a force pulse is studied. Analysis of the transmission of a dilatation wave in a periodically stiffened plate indicates that the stiffeners are fairly transparent to the wave, but some of the dilatational energy is scattered into bending at each support

Force Limited Vibration Testing Monograph

The practice of limiting the shaker force in vibration tests was investigated at the NASA Jet Propulsion Laboratory (JPL) in 1990 after the mechanical failure of an aerospace component during a vibration test. Now force limiting is used in almost every major vibration test at JPL and in many vibration tests at NASA Goddard Space Flight Center (GSFC) and at many aerospace contractors. The basic ideas behind force limiting have been in the literature for several decades, but the piezo-electric force transducers necessary to conveniently implement force limiting have been available only in the last decade. In 1993, funding was obtained from the NASA headquarters Office of Chief Engineer to develop and document the technology needed to establish force limited vibration testing as a standard approach available to all NASA centers and aerospace contractors. This monograph is the final report on that effort and discusses the history, theory, and applications of the method in some detail

Feasibility Analysis of Interleukin-13 as a Target for a Therapeutic Vaccine

Background: The development of therapeutic vaccines requires thorough knowledge of potential hazards associated with long-term inactivation of self-proteins. Among potential targets, interleukin 13 (IL-13) merits consideration, as monoclonal antibodies disrupting IL-13 signaling are proving to be exceedingly effective in common conditions such as atopic dermatitis. Objective: Given the mass publication of scientific data, an appraisal of safety aspects is challenging. Methods: We here provide a three-fold approach to survey clinically relevant information on off-target effects, both adverse and beneficial, that may potentially be encountered in patients undergoing long-term IL-13 inactivation. First, we review non-clinical data in vivo and in vitro. Second, we summarize safety data accumulating from patients dosed with anti-IL-13 drugs. Third, we exploit human mutation data as well as emerging large-scale genetic datasets (global exome data from 60,000 patients) to obtain information on any association of IL-13-inactivating genetic variants with disease states. In addition, we: (1) dissect the precise efficacy signals obtained with various drugs targeting IL-13 and/or IL-4, and (2) summarize unintended, but potentially beneficial effects of prolonged IL-13 inactivation on several functional systems. Results: Prolonged repression of IL-13 in several thousand patients so far has not uncovered any non-redundant functions of IL-13 in immune defense. Furthermore, missense mutations in the key genes IL-13, IL-13Rα1, IL-13Rα2, IL-4, IL-4Rα are common, while no case reports have been published on any immune deficiency or increased risk of neoplastic disease associated with such mutations, suggesting that these genes do not harbor non-redundant roles in adult outbred humans. In terms of efficacy, data from clinically used drugs strongly suggest that targeting IL-13 only, as opposed to IL-13 and IL-4, may be effective in eczema while being more selective. Importantly, several lines of evidence suggest that inhibition of IL-13 may in fact harbor potentially beneficial effects on non-targeted systems, including glucose metabolism, hepatic fibrosis, and atherosclerosis, suggesting that respective outcomes should be systematically captured in patients dosed with IL-13 interfering drugs. Collectively, available evidence suggests that IL-13 may fulfill safety requirements required for the target of a therapeutic vaccine

Techniques for improving the low-frequency performance of small reverberation chambers

Small reverberation chamber low frequency performance characteristic